Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Phase II national, multicenter, double-blind, randomized, placebo-controlled, phase-3
clinical trial of 3 parallel groups.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Collaborators:
Clinica Universidad de Navarra, Universidad de Navarra Gregorio Marañón Hospital Hospital Clínico Universitario de Valladolid Hospital General Universitario de Alicante Hospital Universitario La Fe Hospital Universitario La Paz Hospital Universitario Virgen de la Arrixaca Hospital Victoria Eugenia Cruz Roja Española University of Salamanca